openPR Logo
Press release

Rapid Medical Diagnostic Devices Market- Trends, 2025

10-04-2017 01:36 PM CET | Health & Medicine

Press release from: Medical Device By CMI

Rapid medical diagnosis test is performed within very less time by the use of medical devices, which deliver results in less than two hours. Fast and accurate diagnosis helps doctors to prescribe the appropriate medication in a short span of time. Increasing disease rate, such as diabetes, cardiovascular diseases, infectious diseases, sexually transmitted disease, hepatitis, and gastrointestinal diseases are expected to support the growth of rapid medical diagnostic devices market in the near future. According to Centers for Disease Control and Prevention (CDC), in 2014, around 21 million people were diagnosed with diabetes in the U.S. According to National Institute of Allergy and Infectious Diseases, annually 50,000 new cases of HIV are reported and around 33 million people are infected with HIV globally. Rapid medical diagnostic devices are easy to use and do not require trained person to perform the test. Gone are the days when the physician had to rely on laboratory reports which consumed a long time in processing and providing results. Rapid medical diagnostic devices have provided a new direction to the diagnostic industry by reducing human efforts, and time. There is tremendous growth in rapid medical diagnostic devices market due to easy and convenience of devices for home use.

Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/843

Rapid Diagnostic Medical Devices Market Taxonomy:
By End User
Hospital Laboratories,Clinics,Home (for self-testing)
By Technology
Flow-Through,Lateral Flow,Solid Phase,Agglutination Assays
By Application
Toxicology,Pregnancy,Cardiometabolic,Blood Glucose,Coagulation,Fecal Occult,Infectious Disease
Increase in healthcare facilities and technology expected to fuel the growth of rapid diagnostic medical devices market in near future:
There is a sudden growth in the rapid diagnostic medical device market due to rise in patient awareness level, rising demand of home-based healthcare, constant improvement in healthcare infrastructure and rise in lifestyle disorders such as obesity, which leads to the growth of rapid diagnostic medical devices market. According to World Health Organization (WHO), in 2014, around 13% of adult population was found to be obese globally. Early diagnosis of diseases with the highest accuracy plays a major role in treatment of disease. Tremendous growth in decentralized testing is a major factor driving the growth of rapid diagnostic medical devices market. There is a large scale acceptance of rapid diagnostic medical devices as these devices are available at comparatively low cost than the conventional devices/equipment and gives accurate results for treatment of diseases, such as HIV, tuberculosis, malaria, and syphilis in turn fueling the rapid diagnostic market growth. Advancement in digital technology has boosted the market growth over the forecast period. Due to above mentioned factors, rapid diagnostic market is expected to grow with a higher rate. Increase in healthcare facilities and diseases which support the increase in hospitals and clinics. Increase in pathology labs has propelled the growth of the rapid medical diagnostics market.
Emerging economies are major growth engines of rapid diagnostic medical devices
Globally the rapid diagnostic medical device market is segmented into North America, Latin America, Asia Pacific, the Middle East, and Africa. North America is expected to dominate the rapid diagnostic medical devices market followed by Europe due to high patient awareness, huge healthcare investment, and high prevalence of targeted disease namely HIV in this region. Increasing number of population in with unmet clinical demands in emerging economies such as India and China are expected to fuel growth of rapid medical diagnostics market. Poor healthcare facilities and increase in number of infectious disease such as influenza, malaria, and HIV in African countries will boost the growth of rapid diagnostic medical devices market. According to The foundation for AIDS Research, in 2015, around 36.7 million people were suffering from AIDS in Africa. According to World Health Organization (WHO), in 2015, around 212 million cases of malaria were reported in Africa. Low price of rapid diagnostic medical device as compared with conventional devices is expected to support the growth of rapid diagnostic devices market in this region
Major players contribute to the growth of rapid diagnostic medical devices market
The global market is represented by the wide range of products to fulfill the needs of diagnostic laboratories and physicians. Market players have adopted different technologies such as clinical chemistry, nucleic acid based technology, immunoassay, cell-based assay for clinical application. Companies are also working on product development and marketing strategies to improve their market position. Key players of rapid diagnostic medical devices market include Alere Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter Inc., Abbott, and Siemens Healthcare, ACON Laboratories, Bayer Healthcare, Lifescan, Nipro Diagnostics, Trinity Biotech, Randox Laboratories, Helena Laboratories, Bio-Rad Laboratories, Clarity Diagnostic, Oasis Diagnostics.

Ask For the Discount@
https://www.coherentmarketinsights.com/insight/request-discount/843

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rapid Medical Diagnostic Devices Market- Trends, 2025 here

News-ID: 755234 • Views:

More Releases from Medical Device By CMI

Custom Procedure Trays and Packs Market – Insights
Custom Procedure Trays and Packs Market – Insights
Increasing number of surgical procedures is fuelling the adoption of custom procedure trays and packs (CPTP) market during the forecast period. For instance, according to the WHO, global volume of the surgeries performed in 2012 was estimated to 266.2 to 359.5 million, out of which one in every 20 operations globally was done in very-low-expenditure Member States. Increase in geriatric population, who are more likely to develop chronic wounds as they
Robotic Rehabilitation and Assistive Technologies Market, By Product Type
Robotic Rehabilitation and Assistive Technologies Market, By Product Type
Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent
Spectrophotometer Market : Moving Towards a Brighter Future
Spectrophotometer Market : Moving Towards a Brighter Future
North America is expected to hold dominant position in the market and is also expected to show significant growth in the spectrometer market, due to increasing launch of novel products in the region by key players. For instance, in February 2018, Thermo Fisher Scientific, a U.S.-based company, launched TSQ 9000 Triple Quadrupole GC-MS/MS System. This system has been designed to increase productivity, with enhanced sensitivity, and it also reduces maintenance
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical laboratories use automation for the management of large number of samples through, either total automation systems or high level analyzer automation that are offered by clinical mass spectrometers

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral